Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Let's ConnectCell Separation and Characterization in Solid Tumors: Global Mark...
The global market for cell separation and characterization in solid tumors should grow from $1.8 billion in 2018 to reach $3.3 billion by 2023 at a compound annual growth rate (CAGR) of 12.5% for the period of 2018-2023.
Biomarker Deals: Terms, Value and Trends, 2008-2018
Over the last decade, biomarker research has become one of the essential aspects not only of the in vitro diagnostics industry but an important component of the drug discovery and development process. Moreover, with the growing trend in personalized medicine and companion diagnostics, the use of biomarkers is becoming obligatory in management of certain diseases, such as cancer drug regimen.
Chromatography in Pharmaceuticals and Biotechnology: Global Marke...
The global market for chromatography instruments and reagents should grow from $9.8 billion in 2018 to $14.0 billion in 2023 at a compound annual growth rate (CAGR) of 7.3% from 2018 to 2023.
Protein Analysis: Subfocus on Oncoproteomics
The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.
Genetic Modification Therapies Clinical Applications: Gene Thera...
The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.
Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...
The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.
Switching to CRISPR-Cas Systems from Uncultivated Microbes
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.
Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...
Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.
Immunohistochemistry (IHC): Global Markets to 2022
The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.
The Chinese Market for DNA Sequencing
The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.
Cell Therapy Processing: Global Markets and Technologies
The global market for cell therapy reached $1.3 billion in 2017 and should reach $5.0 billion in 2022 at a compound annual growth rate (CAGR) of 30.9% for the period of 2017-2022.
Mobile Apps for DNA Sequencing: Global Markets
The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.
Global Markets for Enzyme Inhibitors
The global market for enzyme inhibitors should reach $179.9 billion by 2022 from $168 billion in 2017 at a compound annual growth rate (CAGR) of 1.4%, from 2017 to 2022.
Botanical and Plant-derived Drugs: Global Markets
The global market for botanical and plant-derived drugs will grow from $29.4 billion in 2017 to around $39.6 billion by 2022 with a compound annual growth rate (CAGR) of 6.1% for the period of 2017-2022.
Human Microbiome-based Drugs and Diagnostics: Global Markets
The global market for human microbiome-based drugs and diagnostics should reach a market size of nearly $9.9 billion by 2024.
Separation Systems for Commercial Biotechnology
The global market for bioseparation reached $18.4 billion in 2015. This market is expected to increase from $19.0 billion in 2016 to nearly $24.0 billion in 2021 at a compound annual growth rate (CAGR) of 4.7% for 2016-2021.
Global Markets for Protein Labeling
The global protein-labeling market reached $2.2 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 14.1% from 2016 to 2021.
Global Biochip Markets: Microarrays and Lab-on-a-Chip
The global market for biochip products reached nearly $3.9 billion in 2014. This market is projected to grow from $4.7 billion in 2015 to $18.4 billion in 2020, representing a compound annual growth rate (CAGR) of 31.6% between 2015 and 2020.
Cell Expansion Technologies and Global Markets
The global cell expansion market generated revenue of roughly $8.5 billion in 2014, and is expected to reach revenues of $9.7 billion in 2015 and $22.0 billion by 2020, with a compound annual growth rate (CAGR) of 17.8% from 2015 to 2020.
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Ma...
The global market for nucleic acid aptamers reached $340.5 million in 2014. This market should grow to about $610.3 million in 2015 and about $5.4 billion in 2019, with a compound annual growth rate (CAGR) of 73.5% from 2014 to 2019.
Global Markets for Nanoparticle Size Analysis Instrumentation in ...
The global market for nanoparticles instrumentation in life sciences was $5.6 billion in 2013. This value is expected to increase to $5.9 billion in 2014 and about $7.8 billion by 2019, a compound annual growth rate (CAGR) of 5.7% for the five-year period, 2014 to 2019.
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Glo...
The global G protein, coupled receptors (GPCR) targeting drug market sharply fell in the last three years due to a series of patent expirations of blockbuster products. The market receded from nearly $111 billion to almost $100 billion with a -3.4% compound annual growth rate (CAGR) between 2010 and 2013. With the introduction of novel pharmacecuticals and newly appearing classes of drugs, BCC Research expects this market to reach $114 billion by 2018, a CAGR of 2.7% from 2013 to 2018.
Global Markets and Manufacturing Technologies for Protein Drugs -...
This report explores present and future strategies within the protein therapeutics market with a particular focus on blood factors, vaccines and peptide antibiotics. The report includes sales forecasts for year 2013 and 2018.
Global Markets and Manufacturing Technologies for Protein Drugs -...
This report explores present and future strategies within the protein therapeutics market with a particular focus on cytokines and monoclonal antibodies. The report includes sales forecasts for year 2013 and 2018.
Global Markets and Manufacturing Technologies for Protein Drugs -...
This report explores present and future strategies within the protein therapeutics market with a particular focus on peptide hormones and therapeutic enzymes. The report includes sales forecasts for year 2013 and 2018.
Global Microbiome Sequencing Market
This report provides an overview of the global market for microbiome sequencing.
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets
This report offers an in-depth analysis of the GPCR targeting technologies and global market, including market forecasts and sales projections for 2029. It examines the market by segmenting it into various product categories.
Biologic Therapeutic Drugs: Technologies and Global Markets
This report provides an overview of the global biologic therapeutic drugs market and analyzes market trends. The report includes global revenue ($ Million) for base year data of 2023 and estimated data for the forecast period 2024 through 2029. The market is segmented based on product types, applications, sources, and regions.
Global Markets and Manufacturing Technologies for Protein Drugs
This report provides an overview of the global markets for protein drugs and drug manufacturing technologies.
Cell Line and Membrane Market
This report provides an overview of the cell line and membrane market and analyses market trends. The report includes global revenue ($ Millions) for base year data for 2023 and estimated data for the forecast period 2024 through 2029.
Global Biochip Markets: Microarrays and Lab-on-a-Chip
This report provides an overview of the global biochip markets.
Proteomics: Technologies and Global Markets
This report provides an overview of the global proteomics market and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030
Human Microbiome-based Drugs and Diagnostics: Global Markets
The report provides an overview of the global human microbiome-based drugs and diagnostics market and analyzes market trends.
Global DNA Forensic Market
This report provides an overview of the global DNA forensics market and analyzes market trends. It includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.
Global Blood Platelet Market
The report provides an overview of the global blood platelets market and analyzes market trends.
